Csenge Advisory Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,067
| Closed | -$271K | – | 708 |
|
|
2024
Q3 | $271K | Sell |
4,067
-226
| -5% | -$15.1K | 0.01% | 589 |
|
|
2024
Q2 | $254K | Sell |
4,293
-538
| -11% | -$31.8K | 0.01% | 556 |
|
|
2024
Q1 | $385K | Sell |
4,831
-21
| -0.4% | -$1.68K | 0.02% | 492 |
|
|
2023
Q4 | $383K | Sell |
4,852
-153
| -3% | -$12.1K | 0.02% | 473 |
|
|
2023
Q3 | $349K | Sell |
5,005
-8,705
| -63% | -$608K | 0.02% | 452 |
|
|
2023
Q2 | $948K | Sell |
13,710
-805
| -6% | -$55.7K | 0.06% | 223 |
|
|
2023
Q1 | $1.08M | Buy |
14,515
+1,426
| +11% | +$106K | 0.08% | 191 |
|
|
2022
Q4 | $1.22M | Buy |
13,089
+1,329
| +11% | +$124K | 0.09% | 188 |
|
|
2022
Q3 | $1.12M | Sell |
11,760
-1,034
| -8% | -$98.7K | 0.09% | 188 |
|
|
2022
Q2 | $1.19M | Buy |
12,794
+541
| +4% | +$50.1K | 0.1% | 176 |
|
|
2022
Q1 | $1.24M | Buy |
12,253
+4,172
| +52% | +$422K | 0.1% | 182 |
|
|
2021
Q4 | $664K | Sell |
8,081
-676
| -8% | -$55.5K | 0.06% | 277 |
|
|
2021
Q3 | $736K | Buy |
8,757
+676
| +8% | +$56.8K | 0.06% | 282 |
|
|
2021
Q2 | $664K | Buy |
8,081
+1,637
| +25% | +$135K | 0.06% | 278 |
|
|
2021
Q1 | $477K | Sell |
6,444
-755
| -10% | -$55.9K | 0.05% | 285 |
|
|
2020
Q4 | $492K | Buy |
7,199
+172
| +2% | +$11.8K | 0.06% | 226 |
|
|
2020
Q3 | $409K | Buy |
7,027
+2,957
| +73% | +$172K | 0.06% | 239 |
|
|
2020
Q2 | $264K | Buy |
+4,070
| New | +$264K | 0.04% | 298 |
|
|
2019
Q4 | – | Sell |
-3,871
| Closed | -$245K | – | 294 |
|
|
2019
Q3 | $245K | Sell |
3,871
-179
| -4% | -$11.3K | 0.07% | 230 |
|
|
2019
Q2 | $221K | Sell |
4,050
-195
| -5% | -$10.6K | 0.08% | 172 |
|
|
2019
Q1 | $228K | Sell |
4,245
-14,108
| -77% | -$758K | 0.08% | 178 |
|
|
2018
Q4 | $1.2M | Buy |
18,353
+3,964
| +28% | +$260K | 0.44% | 49 |
|
|
2018
Q3 | $1.15M | Buy |
14,389
+8,031
| +126% | +$641K | 0.45% | 46 |
|
|
2018
Q2 | $409K | Buy |
6,358
+1,340
| +27% | +$86.2K | 0.15% | 140 |
|
|
2018
Q1 | $312K | Buy |
5,018
+348
| +7% | +$21.6K | 0.11% | 190 |
|
|
2017
Q4 | $339K | Buy |
4,670
+1,720
| +58% | +$125K | 0.12% | 158 |
|
|
2017
Q3 | $240K | Buy |
+2,950
| New | +$240K | 0.09% | 206 |
|